Using novel machine learning tools developed at Stanford Medicine, researchers have mapped three distinct cellular configurations that correspond to clinical outcomes for patients with a rare, difficult-to-treat cancer called ...
Mar 27, 2024
0
28
A stem cell therapy for Crohn's disease developed by UC Davis Health researchers has shown promising results in mouse studies.
Jan 29, 2024
0
73
A research collaboration has developed a technology capable of extracting mesenchymal stem cells (MSCs) directly from pure bone marrow—also known as bone marrow aspirate (BMA), a pivotal source of MSCs—without dilution.
Nov 15, 2023
0
14
Artificial intelligence has exploded in popularity and is being harnessed by some scientists to predict which molecules could treat illnesses, or to quickly screen existing medicines for new applications.
Oct 18, 2023
0
63
Metastases and resistance to chemotherapy are the main causes of treatment failure and mortality in cancer patients. Epithelial-mesenchymal transition (EMT), a process by which cancer cells detach from their neighboring cells ...
Aug 2, 2023
0
17
Lung mesenchymal cells, which are critical components of the lung's unique structure, also play important roles in disease and recovery from injury, yet knowledge is limited about their biology or how they initiate diseases ...
Jun 13, 2023
0
37
For most types of cancer, the primary tumor is not the cause of death, but metastasis, the dissemination of cancer cells throughout the body. Metastatic progression is a complex cascade of steps, and there can be a significant ...
Jun 7, 2023
0
27
Using new genetic tools to study statins in human cells and mice, Stanford Medicine researchers and collaborators have uncovered how the cholesterol-lowering drugs protect the cells that line blood vessels.
May 11, 2023
0
127
Despite the recent development of new targeted therapies, chemotherapies remain the most frequently used treatment to treat patients suffering from advanced cancers. Chemotherapy resistance is one of the main causes of treatment ...
Mar 22, 2023
0
61
Physician-scientists at The Texas Heart Institute announced today the results of the largest cell therapy trial to date in patients with chronic heart failure due to low ejection fraction. The therapy benefited patients by ...
Feb 27, 2023
0
410
